Clinical Conversations » Podcast Feed

Informações:

Synopsis

Stay informed of the most relevant medical developments by subscribing to Clinical Conversations (http://podcasts.jwatch.org), from NEJM Journal Watch. This podcast features a round-up of the week's top medical stories, clinically-oriented interviews and listeners commentsin 30 minutes or less. Produced by the publishers of the New England Journal of Medicine, NEJM Journal Watch (jwatch.org) delivers independent, practical, and concise information you can trust.

Episodes

  • Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2

    02/09/2022 Duration: 14min

    A VIDEO RECORDING OF THIS INTERVIEW WILL BE AVAILABLE WITHIN A FEW DAYS. [display podcast] In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less […] The post Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 first appeared on Clinical Conversations.

  • Podcast 301: Monkeypox — what to look for, how to treat

    19/08/2022 Duration: 17min

    A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. This time, we look to New York for guidance on recognizing and treating monkeypox. Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum of Einstein will lead you through the monkeypox thicket in a 17-minute chat. Included below is information for patients as well as links to some key […] The post Podcast 301: Monkeypox — what to look for, how to treat first appeared on Clinical Conversations.

  • Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer

    11/08/2022 Duration: 09min

    A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. We’re back with another interview from this year’s IASLC conference. This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mariano Provencio about the survival outcomes from the NADIM II trial. In that trial, patients with resectable stage III AB non-small cell lung cancer received nivolumab plus chemotherapy […] The post Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer first appeared on Clinical Conversations.

  • Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial

    09/08/2022 Duration: 14min

    A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. Interim results on overall survival in phase 3 of the IMpower010 trial were presented at this year’s meeting of the International Assosciation for the Study of Lung Cancer (IASLC). As part of the NEJM Group’s coverage of the conference, Christine Sadlowski interviewed the presenter, Dr. Enriqueta Felip. […] The post Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial first appeared on Clinical Conversations.

  • Podcast 297: Forget about all that vitamin D testing!

    28/07/2022 Duration: 12min

    A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Steven Cummings has co-written a take-no-prisoners editorial in the New England Journal of Medicine. The topic? Vitamin D supplements. The conclusion? “…providers should stop screening for 25-hydroxyvitamin D levels or recommending vitamin D supplements, and people should stop taking vitamin D […] The post Podcast 297: Forget about all that vitamin D testing! first appeared on Clinical Conversations.

  • Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style?

    20/07/2022 Duration: 29min

    A VIDEO RECORDING OF THIS ROUNDTABLE IS AVAILABLE HERE. Your host is old enough to remember when hospital corridors featured physicians with little black bags, scurrying around to see their patients. That’s no longer true, of course. Most of the physicians seen in those corridors these days are white-coated employees. The Annals of Internal Medicine reported a few […] The post Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style? first appeared on Clinical Conversations.

  • Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?

    06/07/2022 Duration: 15min

    CREST-2’s results are probably more than a year away. In the meantime, what to do about diagnosed severe (but asymptomatic) carotid stenosis? Recent results suggest that medical management compares favorably with the surgical approach. In this edition, we address the question with a conversation between Dr. Allan Brett, NEJM Journal Watch‘s editor-in-chief, and Dr. Seemant Chaturvedi, […] The post Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results? first appeared on Clinical Conversations.

  • Podcast 294: PD-1 blockade in locally advanced rectal cancer

    29/06/2022 Duration: 13min

    Locally advanced rectal cancer usually receives a three-part treatment: chemotherapy followed by radiotherapy and then surgery. In a small-cohort study presented at this year’s ASCO conference researchers used a PD-1 inhibitor — dostarlimab — every three weeks for 6 months against the disease. All patients had mismatch repair deficient tumors. No other treatments were needed however, […] The post Podcast 294: PD-1 blockade in locally advanced rectal cancer first appeared on Clinical Conversations.

  • Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate

    27/06/2022 Duration: 11min

    Patients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified and treated as having HER2-negative disease. However, Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center and a group of international collaborators explored the use of a monoclonal antibody–drug conjugate (trastuzumab–deruxtecan) in patients with disease they classify as HER2-“low.” Compared […] The post Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate first appeared on Clinical Conversations.

  • Podcast 292: Informed consent and apnea testing for death — or — What is death, anyway?

    17/06/2022 Duration: 14min

    Apnea testing is part of the protocol used to determine whether a patient is dead according to neurologic criteria. The question is, do clinicians need to obtain consent to proceed? In a fascinating 15-minute chat, two intensivists, Drs. Patricia Kritek and Robert Truog, discuss that question and another, larger one: what is death, anyway? Their back-and-forth […] The post Podcast 292: Informed consent and apnea testing for death — or — What is death, anyway? first appeared on Clinical Conversations.

  • Podcast 291: Unionized nursing homes had lower mortality during Covid-19

    24/05/2022 Duration: 13min

    In the early waves of the Covid-19 pandemic why did patients in unionized nursing homes, have a roughly 10% lower rate of mortality than those in non-unionized ones? A report in Health Affairs tries to sort out the possible reasons. Listen to our 13-minute interview, which raises the question: Should you send your patients to non-unionized facilities? […] The post Podcast 291: Unionized nursing homes had lower mortality during Covid-19 first appeared on Clinical Conversations.

  • Podcast 290: USPSTF’s new take on aspirin and primary prevention of CVD

    08/05/2022 Duration: 14min

    The U.S. Preventive Services Task Force recently issued its sixth set of guidelines on using daily aspirin to prevent cardiovascular disease. The guidelines appeared in JAMA — whose editors asked our guest, Dr. Allan Brett, to write an editorial evaluation. This edition carries Brett’s advice on using the new guidelines in daily clinical practice. Brett’s JAMA editorial USPSTF […] The post Podcast 290: USPSTF’s new take on aspirin and primary prevention of CVD first appeared on Clinical Conversations.

  • Podcast 289: Saline versus balanced crystalloids — what to choose

    04/05/2022 Duration: 16min

    Saline or balanced crystalloids? The question of which resuscitation fluid to use in clinical practice seems to have been settled by recent research findings — or at least settled in favor of balanced crystalloids. But wait, our guests see slight differences that may affect your choice. Patricia Kritek practices critical care medicine at the University of […] The post Podcast 289: Saline versus balanced crystalloids — what to choose first appeared on Clinical Conversations.

  • Podcast 288: Following up with a Ukrainian narcologist

    21/04/2022 Duration: 15min

    Spend 15 minutes with Dr. Natalia Shevchuk, whom we interviewed by candlelight last month. She is sheltering in the Odessa region now, having left the Donetsk area. This time, she relates how she lost a colleague in Russia’s attack on the Kramatorsk railway station and found another she’d feared lost in Mariupol. She told us that […] The post Podcast 288: Following up with a Ukrainian narcologist first appeared on Clinical Conversations.

  • Podcast 287: Thinking about quality-of-life in migraine

    10/04/2022 Duration: 13min

    During the American Academy of Neurology’s 2022 meeting in Seattle, Dr. Richard Lipton of Albert Einstein College of Medicine took questions from Dr. Teshamae Monteith (U. Miami) and Joe Elia. Lipton’s group sought to characterize the impact of patients’ monthly headache days on their quality of life, especially the role of depression, allodynia, and anxiety. (Read […] The post Podcast 287: Thinking about quality-of-life in migraine first appeared on Clinical Conversations.

  • Podcast 286: Talking about addiction treatment by candlelight from Ukraine’s Donetsk region

    21/03/2022 Duration: 19min

    Dr. Natalia Shevchuk (pictured above) treats substance use disorders in Ukraine’s Donetsk region. Her face is candlelit because her town is under curfew, and people aren’t allowed to put on their room lights (if they have electricity) in the hours of darkness, lest Russian bombardments use the lights as guides. She talked with Dr. Ali Raja […] The post Podcast 286: Talking about addiction treatment by candlelight from Ukraine’s Donetsk region first appeared on Clinical Conversations.

  • Podcast 285: GERD’s revised guidelines — an internist and a gastroenterologist discuss them.

    11/03/2022 Duration: 23min

    Gastroesophageal reflux, or GERD, was the focus of a revised set of guidelines issued in January in the American Journal of Gastroenterology. Given the frequency of that condition in primary care clinics, internist and NEJM Journal Watch editor-in-chief Allan Brett proposed a discussion about the practical application of these guidelines with David Bjorkman. Dr. Bjorkman, […] The post Podcast 285: GERD’s revised guidelines — an internist and a gastroenterologist discuss them. first appeared on Clinical Conversations.

  • Podcast 284: The clinical situation in Ukraine

    08/03/2022 Duration: 19min

    Some 85 years ago Guernica was bombed, and after that came Dresden, Coventry, Hiroshima, Bach Mai, and the rest. This episode of Clinical Conversations asks how it might be possible to help clinicians under bombardment in Ukraine. As you will hear, one hospital in Chernihiv keeps all but essential staff away from its buildings when […] The post Podcast 284: The clinical situation in Ukraine first appeared on Clinical Conversations.

  • Podcast 283: More data — this time from the U.K. — about post-Covid vaccination

    22/02/2022 Duration: 10min

    You want more evidence that post-recovery vaccination against Covid-19 reinfection helps? Here is a careful study from the U.K. that followed some 35,000 health care workers — initially without symptoms — in over 100 institutions there. Starting in June 2020 the SIREN study tested these people regularly, with blood sampling every month and nasal swabs […] The post Podcast 283: More data — this time from the U.K. — about post-Covid vaccination first appeared on Clinical Conversations.

  • Podcast 282: Vaccination after Covid-19 recovery prolongs natural immunity to reinfection

    17/02/2022 Duration: 14min

    Governments’ directives about how and when to vaccinate people who’ve recovered from Covid-19 vary widely. But, according to this episode’s guest, Dr. Ronen Arbel, they all say they don’t have enough evidence to set firm policy. So, Arbel and his colleagues set out to collect evidence from some 150,000 patients’ records in Israel who’d recovered […] The post Podcast 282: Vaccination after Covid-19 recovery prolongs natural immunity to reinfection first appeared on Clinical Conversations.

page 1 from 2